FindTrial
Sign In

To study Karveeradya taila as medicine in Eczema in comparison to Clobetasol propionate with Emollient.

A standard controlled clinical study of Karveeradya taila and Clobestol propionate with Emollient in management of garvishajanya Vicharchika with special reference to Eczema.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/03/018294
Enrollment
66
Registered
2019-03-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L20-L30- Dermatitis and eczema

Interventions

Intervention1: Local application of Karveeradya taila: Group A of 33 people having Garvishajanya Vicharchika will be given Karveeradya taila for local application for 21 days Control Intervention1: Lo

Sponsors

PDEAs College of Ayurved and Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient with history of viruddha ahar sevan. 2.Patient with symptoms of Vicharchika

Exclusion criteria

Exclusion criteria: Known case of Diabetis mellitus,HIV Any type of secondary infection at site like infection. Known case of Pittaj vicharchika

Design outcomes

Primary

MeasureTime frame
To study the effect of Karveradya taila in Garvishajanya Vicharchika comparison with Clobetasol propionate with special reference to EczemaTimepoint: Daily twice in a day for 21 days. Follow up on 7,14,21 day—

Secondary

MeasureTime frame
1.To apply Karveeradya taila and see its effect. 2.To apply clobetasol propionate and see its effect. 3.To apply Karveeradya taila and Clobetasol propionate as per signs and symptoms. 4.To observe the adverse effect of drug, if anyTimepoint: Daily twice in a day for 21 days. Follow up On 7,14,21 day—

Countries

India

Contacts

Public ContactDr Jayant Phadke

PDEAs College of Ayurveda and Research Centre Nigdi

jayantphadke10@gmail.com9822615265

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026